AGT antibody (Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8)) (C-Term)

Details for Product anti-AGT Antibody No. ABIN2197581
Antigen
Epitope
C-Term
22
15
15
10
8
5
5
4
4
4
4
4
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
Reactivity
Human
224
74
67
3
2
2
2
2
2
1
1
Host
Rabbit
195
65
2
Clonality
Polyclonal
Conjugate
This AGT antibody is un-conjugated
21
14
6
6
6
6
6
6
5
3
2
2
2
2
2
2
2
Application
Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
153
98
69
34
26
16
14
14
10
8
7
4
4
3
1
1
Options
Immunogen Synthetic peptide selected from the C-terminal region of human AGT (KLH).
Isotype IgG
Cross-Reactivity Human
Cross-Reactivity (Details) Calculated cross reactivity: Hu
Characteristics AGT, CT (Angiotensinogen, Serpin A8, Angiotensin-1, Angiotensin I, Ang I, Angiotensin-2, Angiotensin II, Ang II, Angiotensin-3, Angiotensin III, Ang III, Des-Asp[1]-angiotensin II, SERPINA8)
Purification Purified by ammonium sulfate precipitation.
Antigen
Alternative Name AGT (AGT Antibody Abstract)
NCBI Accession NP_000020
UniProt P01019
Pathways JAK-STAT Signaling, ACE Inhibitor Pathway, EGFR Signaling Pathway, Peptide Hormone Metabolism, Regulation of Systemic Arterial Blood Pressure by Hormones, Regulation of Lipid Metabolism by PPARalpha, Protein targeting to Nucleus, Feeding Behaviour, Monocarboxylic Acid Catabolic Process, Dicarboxylic Acid Transport, Positive Regulation of Response to DNA Damage Stimulus, Regulation of long-term Neuronal Synaptic Plasticity
Application Notes Optimal working conditions should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Buffer Supplied as a liquid in PBS, 0.09 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Storage Comment -20°C